Key result
An implantable haemodynamic monitoring device provided semi-invasive cardiac output measurements that strongly correlated with invasive techniques over 11 months.
Why the study?
Does an implantable haemodynamic monitoring device accurately measure cardiac output compared to invasive techniques in patients with chronic heart failure or pulmonary disease?
Observational (n=5)
Does an implantable haemodynamic monitoring device accurately measure cardiac output compared to invasive techniques in patients with chronic heart failure or pulmonary disease?
Answers are grounded in this paper and cite their sources.
Repeated semi-invasive cardiac output measurements using an implanted haemodynamic monitoring system are feasible and correlate strongly with invasive techniques over 11 months.
Long-term monitoring of central haemodynamics with implanted monitoring systems might be valuable in managing heart failure patients. Such systems offer an opportunity for repeated 'semi-invasive' cardiac output determinations according to the Fick principle. Five patients, four with chronic heart failure and one with chronic pulmonary disease, underwent supine exercise testing during cardiac catheterization at 0, 2, 6 and 11 months after implantation of a right ventricular mixed venous oxygen saturation sensor connected to an implantable haemodynamic monitor. The monitor provided a continuous measure of oxygen saturation via a radio-telemetry link to a metabolic cart capable of measurement of breath-by-breath oxygen consumption. Cardiac output was computed using oxygen consumption, mixed venous oxygen saturation, arterial oxygen saturation by pulse oximetry and haemoglobin oxygen capacity. Biosensor-derived oxygen saturation compared to blood samples from the pulmonary artery showed an excellent correlation over time, r2 = 0.94 (implant), r2 = 0.91 (6-11 months). There was a strong correlation between semi-invasive-determined cardiac output using the biosensor and the invasive technique, which persisted over the entire follow-up period. Repeated semi-invasive cardiac output measurements using an implanted haemodynamic monitoring system in chronic heart failure patients is feasible and the data may be of value for optimizing therapy.
No takes yet. Share an insight, caveat, or question.
Ohlsson et al. (1996) conducted an observational in Chronic heart failure and chronic pulmonary disease (n=5). Implantable haemodynamic monitoring device vs. Invasive technique (pulmonary artery blood samples) was evaluated on Correlation of biosensor-derived oxygen saturation with pulmonary artery blood samples (r2 = 0.91 at 6-11 months). An implantable haemodynamic monitoring device provided semi-invasive cardiac output measurements that strongly correlated with invasive techniques over 11 months.
Synapse has enriched 10 related papers. Consider them for comparative context: